We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Neonatal Hyperbilirubinemia Admissions Following Clinical Practice Guideline Implementation.
- Authors
Smith, Morgan; Ridgway, Austin; Mullikin, Dolores
- Abstract
Introduction Treatment of neonatal hyperbilirubinemia remains one of the most common reasons for readmission following delivery. Revised clinical practice guidelines (CPGs) for the treatment of neonatal hyperbilirubinemia were published on August 5, 2022. This report describes the preliminary outcomes following implementation of the new CPGs at Tripler Army Medical Center. Materials and Methods A retrospective chart review was performed for the 12 months prior to implementation and the 5 months post implementation. Results Bilirubin admissions decreased from 15.6% of total admissions during the 12 months prior to the new guidelines (69/441) to 4.1% of admissions (8/194) during the 5 months after implementation of the new guidelines (P < 0.001). This corresponds to a 74% reduction (risk ratio = 0.26, 95% confidence interval [CI] 0.13 to 0.54). The decrease in admissions was found to correlate to greater than $140,000 in annual savings. Conclusion Adhering to the revised CPGs has the potential to increase resource availability at a time when nursing shortages and financial instability are impacting health care systems nationwide. No short-term adverse events were noted; however, long-term follow up will be needed.
- Subjects
NEONATAL jaundice; NURSE supply &; demand; MEDICAL care; BILIRUBIN; PATIENT readmissions
- Publication
Military Medicine, 2024, Vol 189, Issue 5/6, pe1259
- ISSN
0026-4075
- Publication type
Article
- DOI
10.1093/milmed/usad427